CIENCIASMEDICASNEWS: Fogarty International Center

sábado, 10 de noviembre de 2018

Fogarty International Center

Fogarty International Center

Funding news for global health researchers and partners from Fogarty at NIH

On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research. Updates are typically distributed once a week.

Funding Opportunities

NIH funding opportunities focusing on global health and foreign collaboration.

Updated > Additional updates to Fogarty's Emerging Global Leader Award:
- Reissue with new application deadline for 2018:
  Emerging Global Leader Award (K43 Independent Clinical Trial Required) (PAR-19-051)
  Application receipt dates: December 4, 2018; November 7, 2019; and November 4, 2020
- Notice of Change in Receipt Date for the Emerging Global Leader Award (K43) (Independent Clinical Trial Not Allowed) (PAR-17-001) (NOT-TW-18-009)
  Application receipt date: December 4, 2018
Global Noncommunicable Diseases and Injury Across the Lifespan: Exploratory Research (R21 Clinical Trials Optional) (PAR-19-059)
Application receipt dates: December 13, 2018, December 13, 2019
More about Fogarty's Global Noncommunicable Diseases and Injury Research program.
Notice of National Institute of Dental and Craniofacial Research (NIDCR) participation in Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (PAR-18-901) (D43 Clinical Trial Optional) (NOT-DE-18-025) and PAR-17-097 (D71) (NOT-DE-18-026)
Note: NIDCR is interested in research training programs that develop research capacity to improve dental, oral and craniofacial health across the lifespan.
Notice to Extend the Expiration Date and Change Receipt Dates for Global Brain and Nervous System Disorders Research Across the Lifespan PAR-18-835 (R01 Clinical Trials Optional) (NOT-TW-18-007) and PAR-18-836 (R21 Clinical Trial Optional) (NOT-TW-18-008)
Partnerships for Enhanced Engagement in Research (PEER) funding:
- Submitting a pre-proposal for Partnerships for Enhanced Engagement in Research (PEER)? Join an applicant webinar on November 14, 2018. Please register to participate. PEER, which supports research and capacity-building activities on topics with strong potential development impacts, is supported by the United States Agency for International Development (USAID) and other U.S. Government-supported agencies, including NIH.
  Pre-proposals deadline: January 14, 2019
- Expanding Cervical Cancer Screening and Preventive Therapy (CCS&PT) through Introducing New Technologies and Integrating with Voluntary Family Planning, a sub-program of PEER, will host applicant webinars on November 15, 2018. Two session will be offered. Please register to participate.
  Deadline for partnership proposals: December 11, 2018

NIH funding opportunities for which foreign organizations, foreign components of U.S. organizations and/or other foreign components may apply.

Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional) (PA-19-042) and (R21 Clinical Trial Optional) (PA-19-050)
Application Receipt/Submission Date(s): Standard AIDS dates apply
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional) (PAR-19-044) and (R01 Clinical Trial Optional) (PAR-19-045)
Application Receipt/Submission Date(s): Standard dates apply
Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional) (PA-19-046) and (R01 Clinical Trial Optional) (PA-19-047)
Application Receipt/Submission Date(s): Standard dates apply
Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed) (RFA-DK-18-014)
Application Receipt Date(s): February 26, 2019
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) (RFA-MH-19-235)
Application Receipt Date(s): February 4, 2019
Lewy Body Dementia Center Without Walls (CWOW) (U54 Clinical Trial Not Allowed) (RFA-NS-19-013)
Application Receipt Date(s): January 4, 2019

NIH funding opportunities for which United States small business concerns (SBCs) may collaborate with a foreign business entity.

Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed) (PA-19-043)
Application Receipt/Submission Date(s): Standard dates apply

Information related to opportunities from other organizations focusing on global health and foreign collaboration.

Conference: Watch the live stream of the Women Leaders in Global Health conference November 8 - 9. Review the full conference program for speaker and schedule information.
Nominations: The Ebola Data Platform is accepting nominations for members of its Data Access Committee. The Ebola Data Platform has been established to develop and promote research on Ebola Virus Disease, and is directed by a steering committee with membership including: National Public Health Institute Liberia, Sierra Leone Ministry of Health and Sanitation, Agence Nationale de Sécurité Sanitaire Guinée, West African Health Organisation, West African Taskforce for Emerging and Re-Emerging Infections, International Medical Corps, Médecins Sans Frontières, University of Oxford, Wellcome and the World Health Organization.
Deadline for nominations: November 23, 2018

Funding News

NIH funding news that may be relevant to global health researchers.

Request for Information (RFI): Soliciting Input on Priorities and Progress in Alzheimer's Disease-Related Dementias Research (NOT-NS-19-011)
Update to NIH Management of Genomic Summary Results Access (NOT-OD-19-023)